Correlation Between Biotron and Advanced Proteome
Can any of the company-specific risk be diversified away by investing in both Biotron and Advanced Proteome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotron and Advanced Proteome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotron Limited and Advanced Proteome Therapeutics, you can compare the effects of market volatilities on Biotron and Advanced Proteome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotron with a short position of Advanced Proteome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotron and Advanced Proteome.
Diversification Opportunities for Biotron and Advanced Proteome
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Biotron and Advanced is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Biotron Limited and Advanced Proteome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Advanced Proteome and Biotron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotron Limited are associated (or correlated) with Advanced Proteome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Advanced Proteome has no effect on the direction of Biotron i.e., Biotron and Advanced Proteome go up and down completely randomly.
Pair Corralation between Biotron and Advanced Proteome
If you would invest 0.98 in Biotron Limited on December 30, 2024 and sell it today you would lose (0.71) from holding Biotron Limited or give up 72.45% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Biotron Limited vs. Advanced Proteome Therapeutics
Performance |
Timeline |
Biotron Limited |
Advanced Proteome |
Biotron and Advanced Proteome Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biotron and Advanced Proteome
The main advantage of trading using opposite Biotron and Advanced Proteome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotron position performs unexpectedly, Advanced Proteome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Advanced Proteome will offset losses from the drop in Advanced Proteome's long position.Biotron vs. biOasis Technologies | Biotron vs. Covalon Technologies | Biotron vs. Mosaic Immunoengineering | Biotron vs. Cellectis SA |
Advanced Proteome vs. Crocs Inc | Advanced Proteome vs. Unilever PLC ADR | Advanced Proteome vs. Timken Company | Advanced Proteome vs. Snap On |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |